Evidence map›Paper›PMID 26499799›Full record

ArticleThe Journal of biological chemistry2016

Probing the Mec1ATR Checkpoint Activation Mechanism with Small Peptides.

Paulina H Wanrooij, Elias Tannous, Sandeep Kumar, Vasundhara M Navadgi-Patil, Peter M Burgers

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. DNA Damage and Replication Stress Checkpoints.Annual review of biochemistry · 2025
    Review
  4. Article
  5. Article
  6. Novel insights into the mechanism of cell cycle kinases Mec1(ATR) and Tel1(ATM).Critical reviews in biochemistry and molecular biology · 2021
    Article
  7. Mechanism of auto-inhibition and activation of Mec1Nature structural & molecular biology · 2021
    Article
  8. Structural basis of homologous recombination.Cellular and molecular life sciences : CMLS · 2020
    Review
  9. Article
  10. Activation of Tel1The Journal of biological chemistry · 2019
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Paulina H WanrooijFrom the Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110, Department of Medical Biochemistry and Biophysics, Umeå University, 901 87 Umeå, Sweden, and.
Elias TannousFrom the Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110.
Sandeep KumarFrom the Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110, Department of Molecular & Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030.
Vasundhara M Navadgi-PatilFrom the Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110.
Peter M BurgersFrom the Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110, burgers@biochem.wustl.edu.
Washington University in St. Louis · US

Funding

KINASE ACTIVATION IN THE DNA DAMAGE CHECKPOINTSR01GM083970 · NIGMS · WASHINGTON UNIVERSITY · PI BURGERS, PETER M · 2009 to 2016
$2.1M
NIGMS NIH HHS GM083970NIGMS NIH HHS R01 GM083970
6 · The paper itself

Abstract

Yeast Mec1, the ortholog of human ATR, is the apical protein kinase that initiates the cell cycle checkpoint in response to DNA damage and replication stress. The basal activity of Mec1 kinase is activated by cell cycle phase-specific activators. Three distinct activators stimulate Mec1 kinase using an intrinsically disordered domain of the protein. These are the Ddc1 subunit of the 9-1-1 checkpoint clamp (ortholog of human and Schizosaccharomyces pombe Rad9), the replication initiator Dpb11 (ortholog of human TopBP1 and S. pombe Cut5), and the multifunctional nuclease/helicase Dna2. Here, we use small peptides to determine the requirements for Mec1 activation. For Ddc1, we identify two essential aromatic amino acids in a hydrophobic environment that when fused together are proficient activators. Using this increased insight, we have been able to identify homologous motifs in S. pombe Rad9 that can activate Mec1. Furthermore, we show that a 9-amino acid Dna2-based peptide is sufficient for Mec1 activation. Studies with mutant activators suggest that binding of an activator to Mec1 is a two-step process, the first step involving the obligatory binding of essential aromatic amino acids to Mec1, followed by an enhancement in binding energy through interactions with neighboring sequences.

Indexed as

Amino Acid MotifsAmino Acid SequenceCell Cycle CheckpointsCell Cycle ProteinsDNA HelicasesEnzyme ActivationEnzyme ActivatorsIntracellular Signaling Peptides and ProteinsModels, MolecularMolecular Sequence DataPeptidesProlineProtein Serine-Threonine KinasesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsCell Cycle ProteinsDdc1 protein, S cerevisiaeDNA2 protein, S cerevisiaeDNA HelicasesEnzyme ActivatorsIntracellular Signaling Peptides and ProteinsMEC1 protein, S cerevisiaePeptidesProlineProtein Serine-Threonine Kinasesrad9 proteinSaccharomyces cerevisiae Proteinscheckpoint controlDNA damage responseenzyme kineticspeptidesserine/threonine protein kinase

Identifiers

PMID26499799
PMCPMC4697174
OpenAlexW2215527210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.